孤立性纤维瘤局部和转移复发预测:法国肉瘤组多中心队列风险计算器的构建
基于法国肉瘤组24个中心214例连续孤立性纤维瘤(SFT)患者数据库,对162例局部病变患者行竞争风险多因素分析并构建局部复发和转移复发预后模型,完成内部和外部验证及个体化风险计算器。10年和20年局部复发率分别为19.2%和38.6%,转移复发率分别为31.4%和49.8%,复发延迟出现提示长期监测有用。
要点
- 10年和20年局部复发率分别为19.2%和38.6%,转移复发率分别为31.4%和49.8%。
- 局部复发影响因素为内脏定位、放疗和年龄;转移复发独立因素为核分裂计数、非肢体定位和年龄。
- 基于不利预后因素数目定义三个总生存预后组,并构建个体化局部和转移复发风险计算器。
核心结论
- 局部复发率和转移复发率在10年至20年间均升高,复发延迟出现,提示长期监测有用。
- 不同SFT预后亚组可能受益于不同治疗策略,使用生存计算器可能成为SFT标准实践以基于临床情况个体化治疗。
研究设计与样本
- 法国肉瘤组多中心队列研究,纳入24个参与癌症中心的214例连续SFT患者进入欧洲数据库。
- 分析限制于162例局部病变患者,采用考虑竞争风险的单因素和多因素分析评估总生存、局部复发率和转移复发率。
- 构建局部复发和转移复发预后模型,并进行内部和外部验证及个体化风险计算器。
主要发现
- 分析时20例患者(12.3%)死亡,中位总生存未达到。
- 10年和20年局部复发率分别为19.2%和38.6%,转移复发率分别为31.4%和49.8%。
- 多因素分析中年龄和核分裂计数对预测总生存趋于显著。
- 影响局部复发的因素为内脏定位、放疗和年龄;核分裂计数、非肢体肿瘤定位和年龄对转移复发有独立价值。
- 基于不利预后因素数目定义三个总生存预后组,并计算个体患者局部和转移复发风险。
关键数值与推荐
- 局部复发率10年19.2%、20年38.6%;转移复发率10年31.4%、20年49.8%。
- 局部复发影响因素:内脏定位、放疗、年龄。
- 转移复发独立因素:核分裂计数、非肢体定位、年龄。
临床怎么用
- 作者认为局部和转移复发在10年至20年间延迟出现,提示长期监测有用。
- 作者认为不同SFT预后亚组可能受益于不同治疗策略。
- 作者认为使用生存计算器可能成为SFT标准实践,以基于临床情况个体化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Solitary fibrous tumors (SFT) are rare unusual ubiquitous soft tissue tumors that are presumed to be of fibroblastic differentiation. At present, the challenge is to establish accurate prognostic factors. PATIENTS AND METHODS: A total of 214 consecutive patients with SFT diagnosed in 24 participating cancer centers were entered into the European database (www.conticabase.org) to perform univariate and multivariate analysis for overall survival (OS), local recurrence incidence (LRI) and metastatic recurrence incidence (MRI) by taking competing risks into account. A prognostic model was constructed for LRI and MRI. Internal and external validations of the prognostic models were carried out. An individual risk calculator was carried out to quantify the risk of both local and metastatic recurrence. RESULTS: We restricted our analysis to 162 patients with local disease. Twenty patients (12.3%) were deceased at the time of analysis and the median OS was not reached. The LRI rates at 10 and 20 years were 19.2% and 38.6%, respectively. The MRI rates at 10 and 20 years were 31.4% and 49.8%, respectively. Multivariate analysis retained age and mitotic count tended to significance for predicting OS. The factors influencing LRI were viscera localization, radiotherapy and age. Mitotic count, tumor localization other than limb and age had independent values for MRI. Three prognostic groups for OS were defined based on the number of unfavorable prognostic factors and calculations were carried out to predict the risk of local and metastatic recurrence for individual patients. CONCLUSION: LRI and MRI rates increased between 10 and 20 years so relapses were delayed, suggesting that long-term monitoring is useful. This study also shows that different prognostic SFT sub-groups could benefit from different therapeutic strategies and that use of a survival calculator could become standard practice in SFTs to individualize treatment based on the clinical situation.
引用
- Salas S, Resseguier N, Blay JY, et al. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol. 2017. PMID: 28838212. doi:10.1093/annonc/mdx250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。